Literature DB >> 29806494

Dysfunctional Nav1.5 channels due to SCN5A mutations.

Dan Han1, Hui Tan2, Chaofeng Sun1, Guoliang Li1.   

Abstract

The voltage-gated sodium channel 1.5 (Nav1.5), encoded by the SCN5A gene, is responsible for the rising phase of the action potential of cardiomyocytes. The sodium current mediated by Nav1.5 consists of peak and late components (INa-P and INa-L). Mutant Nav1.5 causes alterations in the peak and late sodium current and is associated with an increasingly wide range of congenital arrhythmias. More than 400 mutations have been identified in the SCN5A gene. Although the mechanisms of SCN5A mutations leading to a variety of arrhythmias can be classified according to the alteration of INa-P and INa-L as gain-of-function, loss-of-function and both, few researchers have summarized the mechanisms in this way before. In this review article, we aim to review the mechanisms underlying dysfunctional Nav1.5 due to SCN5A mutations and to provide some new insights into further approaches in the treatment of arrhythmias. Impact statement The field of ion channelopathy caused by dysfunctional Nav1.5 due to SCN5A mutations is rapidly evolving as novel technologies of electrophysiology are introduced and our understanding of the mechanisms of various arrhythmias develops. In this review, we focus on the dysfunctional Nav1.5 related to arrhythmias and the underlying mechanisms. We update SCN5A mutations in a precise way since 2013 and presents novel classifications of SCN5A mutations responsible for the dysfunction of the peak (INa-P) and late (INa-L) sodium channels based on their phenotypes, including loss-, gain-, and coexistence of gain- and loss-of function mutations in INa-P, INa-L, respectively. We hope this review will provide a new comprehensive way to better understand the electrophysiological mechanisms underlying arrhythmias from cell to bedside, promoting the management of various arrhythmias in practice.

Entities:  

Keywords:  INa-L; INa-P; Nav1.5; SCN5A; gain-of-function; loss-of-function

Mesh:

Substances:

Year:  2018        PMID: 29806494      PMCID: PMC6022915          DOI: 10.1177/1535370218777972

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  129 in total

1.  Gating of the late Na+ channel in normal and failing human myocardium.

Authors:  Albertas I Undrovinas; Victor A Maltsev; John W Kyle; Norman Silverman; Hani N Sabbah
Journal:  J Mol Cell Cardiol       Date:  2002-11       Impact factor: 5.000

Review 2.  Brugada syndrome.

Authors:  Yuka Mizusawa; Arthur A M Wilde
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-06-01

3.  Delayed afterdepolarization in intact canine sinoatrial node as a novel mechanism for atrial arrhythmia.

Authors:  Boyoung Joung; Hong Zhang; Tetsuji Shinohara; Mitsunori Maruyama; Seongwook Han; Daehyeok Kim; Eue-Keun Choi; Young-Keun On; Shien-Fong Lin; Peng-Sheng Chen
Journal:  J Cardiovasc Electrophysiol       Date:  2010-10-06

4.  Electrophysiological characterization of a large set of novel variants in the SCN5A-gene: identification of novel LQTS3 and BrS mutations.

Authors:  Beatriz Ortiz-Bonnin; Susanne Rinné; Robin Moss; Anne K Streit; Michael Scharf; Katrin Richter; Anika Stöber; Arne Pfeufer; Gunnar Seemann; Stefan Kääb; Britt-Maria Beckmann; Niels Decher
Journal:  Pflugers Arch       Date:  2016-06-11       Impact factor: 3.657

5.  A novel SCN5A mutation demonstrating a variety of clinical phenotypes in familial sick sinus syndrome.

Authors:  Seiko Nakajima; Takeru Makiyama; Koji Hanazawa; Kazuaki Kaitani; Masashi Amano; Yukiko Hayama; Naoaki Onishi; Yodo Tamaki; Makoto Miyake; Toshihiro Tamura; Hirokazu Kondo; Makoto Motooka; Chisato Izumi; Yoshihisa Nakagawa; Minoru Horie
Journal:  Intern Med       Date:  2012-03-01       Impact factor: 1.271

6.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

Authors:  David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343

7.  The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online.

Authors:  Kaate R J Vanmolkot; Elena Babini; Boukje de Vries; Anine H Stam; Tobias Freilinger; Gisela M Terwindt; Lisa Norris; Joost Haan; Rune R Frants; Nabih M Ramadan; Michel D Ferrari; Michael Pusch; Arn M J M van den Maagdenberg; Martin Dichgans
Journal:  Hum Mutat       Date:  2007-05       Impact factor: 4.878

8.  Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias.

Authors:  Heikki Swan; Mohamed Yassine Amarouch; Jaakko Leinonen; Annukka Marjamaa; Jan P Kucera; Päivi J Laitinen-Forsblom; Annukka M Lahtinen; Aarno Palotie; Kimmo Kontula; Lauri Toivonen; Hugues Abriel; Elisabeth Widen
Journal:  Circ Cardiovasc Genet       Date:  2014-09-10

9.  PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function.

Authors:  Diana Shy; Ludovic Gillet; Jakob Ogrodnik; Maxime Albesa; Arie O Verkerk; Rianne Wolswinkel; Jean-Sébastien Rougier; Julien Barc; Maria C Essers; Ninda Syam; Roos F Marsman; Anneke M van Mil; Samuel Rotman; Richard Redon; Connie R Bezzina; Carol Ann Remme; Hugues Abriel
Journal:  Circulation       Date:  2014-06-03       Impact factor: 29.690

10.  A1180V of cardiac sodium channel gene (SCN5A): is it a risk factor for dilated cardiomyopathy or just a common variant in Han Chinese?

Authors:  Cheng Shen; Lei Xu; Zhiyin Yang; Yunzeng Zou; Kai Hu; Zheng Fan; Junbo Ge; Aijun Sun
Journal:  Dis Markers       Date:  2013-10-20       Impact factor: 3.434

View more
  13 in total

1.  Dysfunctional Cav1.2 channel in Timothy syndrome, from cell to bedside.

Authors:  Dan Han; Xiaolin Xue; Yang Yan; Guoliang Li
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-19

Review 2.  Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go?

Authors:  Zhi-Mei Li; Li-Xia Chen; Hua Li
Journal:  Curr Med Sci       Date:  2019-12-16

Review 3.  The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease.

Authors:  Mengru Wang; Xin Tu
Journal:  Front Cardiovasc Med       Date:  2022-06-15

Review 4.  Atrial Fibrillation in Inherited Channelopathies.

Authors:  Baha'a Al-Azaam; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2021-01-08

Review 5.  NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death.

Authors:  Weiyi Xu; Le Li; Lilei Zhang
Journal:  Front Physiol       Date:  2020-08-13       Impact factor: 4.566

6.  Amiodarone-induced life-threatening torsade de pointes in an end-stage lung cancer patient receiving gefitinib.

Authors:  Dan Han; Hui Tan; Chaofeng Sun; Guoliang Li
Journal:  Oxf Med Case Reports       Date:  2019-01-24

Review 7.  Acquired long QT syndrome in chronic kidney disease patients.

Authors:  Peng Liu; Lu Wang; Dan Han; Chaofeng Sun; Xiaolin Xue; Guoliang Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

8.  Structural basis of cytoplasmic NaV1.5 and NaV1.4 regulation.

Authors:  Sara Nathan; Sandra B Gabelli; Jesse B Yoder; Lakshmi Srinivasan; Richard W Aldrich; Gordon F Tomaselli; Manu Ben-Johny; L Mario Amzel
Journal:  J Gen Physiol       Date:  2021-01-04       Impact factor: 4.086

9.  Digenic heterozygous mutations of KCNH2 and SCN5A induced young and early-onset long QT syndrome and sinoatrial node dysfunction.

Authors:  Zhe Yang; Yuting Ma; Jiana Huang; Jianzhong Xian; Yin Huang; Linbo Wu; WenLiang Zhu; Feng Wang; Liang Chen; Xiufang Lin; Yubi Lin
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-11-09       Impact factor: 1.468

10.  In vitro discovery of novel prokaryotic ion channel candidates for antiarrhythmic gene therapy.

Authors:  Tianyu Wu; Hung X Nguyen; Nenad Bursac
Journal:  Methods Enzymol       Date:  2021-04-09       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.